Post by
BioTeck on Jun 01, 2022 10:05am
ViaCyte
Just when we thought they were teets up, they may beat us at getting stem cells in a device into a body. Whether it works or not is another story but A for effort. Partnered with CRISPR for immuno suppression gene editing which sounds like won't be in the clinic this year. https://www.med.ubc.ca/news/b-c-researchers-launching-clinical-trial-for-first-genetically-engineered-stem-cell-based-therapy-for-type-1-diabetes/